title: [Good response of hyperkeratotic palmoplantar psoriasis to ustekinumab].
authors: A
authors: A
authors: Nuño-González
authors: E
authors: E
authors: Gómez de la Fuente
authors: F J
authors: FJ
authors: Vicente-Martín
authors: J L
authors: JL
authors: López-Estebaranz
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000918:Antibody Specificity; D002117:Calcitriol / Q000031:analogs & derivatives / Q000627:therapeutic use; D057176:Compassionate Use Trials; D004351:Drug Resistance; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D053762:Interleukin-12 Subunit p40 / Q000037:antagonists & inhibitors* / Q000276:immunology; D007645:Keratoderma, Palmoplantar / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D000069549:Ustekinumab
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D053762:Interleukin-12 Subunit p40; C055085:calcipotriene; D000069549:Ustekinumab; D002117:Calcitriol